Report Summary
Eternity Insights has published a new study on Global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market focusing on key segments as by Type (Inactivated Vaccine,Live Attenuated Vaccine, Other), by Application (Government Institution,Private Sector,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Hepatitis A Vaccine [Vaccine For Hepatitis A] Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market Segmentation:
Hepatitis A Vaccine [Vaccine For Hepatitis A] Market, By Type
- Inactivated Vaccine
- Live Attenuated Vaccine
- Other
Hepatitis A Vaccine [Vaccine For Hepatitis A] Market, By Application
- Government Institution
- Private Sector
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Hepatitis A Vaccine [Vaccine For Hepatitis A] market in terms of demand generation. The Hepatitis A Vaccine [Vaccine For Hepatitis A] market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Hepatitis A Vaccine [Vaccine For Hepatitis A] market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market Taxonomy:
To learn more about this report
Global Hepatitis A Vaccine [Vaccine For Hepatitis A] Market Competitive Landscape
The global Hepatitis A Vaccine [Vaccine For Hepatitis A] market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- Kaketsuken
- IMBCA
- ChangSheng
- Convac
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Inactivated Vaccine,Live Attenuated Vaccine, Other |
| By Application Outlook |
Government Institution,Private Sector,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
GSK,Merck,Sanofi,Sinovac,Zhejiang Pukang,Changchun Institute of Biological,Kaketsuken,IMBCA,ChangSheng,Convac |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Hepatitis A Vaccine [Vaccine for Hepatitis A] Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Hepatitis A Vaccine [Vaccine for Hepatitis A] Industry Overview
2.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Hepatitis A Vaccine [Vaccine for Hepatitis A] Global Import Market Analysis
2.1.2 Hepatitis A Vaccine [Vaccine for Hepatitis A] Global Export Market Analysis
2.1.3 Hepatitis A Vaccine [Vaccine for Hepatitis A] Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3.2 Private Sector
2.3.3 Other
2.4.2 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Hepatitis A Vaccine [Vaccine for Hepatitis A] Manufacturer Market Share
2.4.5 Top 10 Hepatitis A Vaccine [Vaccine for Hepatitis A] Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Hepatitis A Vaccine [Vaccine for Hepatitis A] Market
2.4.7 Key Manufacturers Hepatitis A Vaccine [Vaccine for Hepatitis A] Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Hepatitis A Vaccine [Vaccine for Hepatitis A] Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Hepatitis A Vaccine [Vaccine for Hepatitis A] Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Regions
4.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue, Sales and Market Share by Regions
4.1.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Market Share by Regions (2015-2020)
4.2 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
4.3 APAC Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
4.4 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
4.5 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Countries
5.1 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Countries
5.1.1 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales by Countries (2015-2020)
5.1.2 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue by Countries (2015-2020)
5.1.3 Germany Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.1.4 UK Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.1.5 France Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.1.6 Russia Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.1.7 Italy Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.1.8 Spain Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
5.2 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Type (2015-2020)
5.3.2 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Application (2015-2020)
6 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Countries
6.1 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue by Countries (2015-2020)
6.1.3 China Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.1.4 Japan Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.1.5 Korea Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.1.6 India Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.1.8 Australia Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Market Share by Application (2015-2020)
7 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Countries
7.1 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Countries
7.1.1 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales by Countries (2015-2020)
7.1.2 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue by Countries (2015-2020)
7.1.3 United States Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
7.1.4 Canada Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
7.1.5 Mexico Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
7.2 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Type (2015-2020)
7.3.2 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Revenue Share by Type (2015-2020)
7.4 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Application (2015-2020)
8 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Countries
8.1 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Countries
8.1.1 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales by Countries (2015-2020)
8.1.2 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue by Countries (2015-2020)
8.1.3 Brazil Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
8.2 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Type (2015-2020)
8.3.2 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Revenue Share by Type (2015-2020)
8.4 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Application (2015-2020)
9 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Size Categorized by Countries
9.1 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue by Countries (2015-2020)
9.1.3 GCC Countries Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
9.1.4 Turkey Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
9.1.5 Egypt Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
9.1.6 South Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Market Share by Application (2015-2020)
10 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Segment by Type
10.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales and Market Share by Type (2015-2020)
10.1.2 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue and Market Share by Type (2015-2020)
10.2 Inactivated Vaccine Sales Growth Rate and Price
10.2.1 Global Inactivated Vaccine Sales Growth Rate (2015-2020)
10.2.2 Global Inactivated Vaccine Price (2015-2020)
10.3 Live Attenuated Vaccine Sales Growth Rate and Price
10.3.1 Global Live Attenuated Vaccine Sales Growth Rate (2015-2020)
10.3.2 Global Live Attenuated Vaccine Price (2015-2020)
11.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A]Sales Market Share by Application (2015-2020)
11.2 Government Institution Sales Growth Rate (2015-2020)
11.3 Private Sector Sales Growth Rate (2015-2020)
11.4 Other Sales Growth Rate (2015-2020)
12.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Revenue, Sales and Growth Rate (2020-2027)
12.2 Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast by Regions (2020-2027)
12.2.1 Europe Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast (2020-2027)
12.2.2 APAC Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast (2020-2027)
12.2.3 North America Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast (2020-2027)
12.2.4 South America Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast (2020-2027)
12.2.5 Middle East & Africa Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast (2020-2027)
12.3 Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast by Type (2020-2027)
12.3.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Forecast by Type (2020-2027)
12.3.2 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Share Forecast by Type (2020-2027)
12.4 Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Forecast by Application (2020-2027)
12.4.1 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Sales Forecast by Application (2020-2027)
12.4.2 Global Hepatitis A Vaccine [Vaccine for Hepatitis A] Market Share Forecast by Application (2020-2027)
13 Analysis of Hepatitis A Vaccine [Vaccine for Hepatitis A] Industry Key Manufacturers
13.1 GSK
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GSK Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GSK News
13.2 Merck
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Merck Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Merck News
13.3 Sanofi
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Sanofi Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Sanofi News
13.4 Sinovac
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Sinovac Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Sinovac News
13.5 Zhejiang Pukang
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Zhejiang Pukang Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Zhejiang Pukang News
13.6 Changchun Institute of Biological
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Changchun Institute of Biological News
13.7 Kaketsuken
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Kaketsuken Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Kaketsuken News
13.8 IMBCA
13.8.1 Company Details
13.8.2 Product Information
13.8.3 IMBCA Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 IMBCA News
13.9 ChangSheng
13.9.1 Company Details
13.9.2 Product Information
13.9.3 ChangSheng Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 ChangSheng News
13.10 Convac
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Convac Hepatitis A Vaccine [Vaccine for Hepatitis A] Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Convac News
15 Appendix